Key result
A 22-year-old woman with primary intracranial Ewing sarcoma underwent gross total excision but experienced a rapid downhill course, developing extracranial metastases at 2 months and dying at 6 months.
Case Report (n=1)
Primary intracranial Ewing sarcoma can present with an unusually aggressive course, particularly when associated with unfavorable prognostic molecular features.
Alerts to possible rapid progression despite resection in primary intracranial Ewing sarcoma; hypothesis-generating for molecular prognostic stratification.
The occurrence of Ewing sarcoma-peripheral primitive neuroectodermal tumor as a primary intracranial tumor is very rare, with only 29 cases reported in the literature, 19 of which have included molecular studies. We present the clinical, radiologic and pathologic findings of an intracranial Ewing sarcoma in a 22-year-old woman arising from the dura over the right frontal convexity. The patient underwent craniotomy with gross total excision of the tumor. The tumor showed atypical histology and the diagnosis was confirmed by detection of a rearrangement of the EWSR1 gene by fluorescent in situ hybridization and identification of the diagnostic t(11;22)(q24;q12) translocation by reverse transcription-polymerase chain reaction. Additional features were detected in this tumor that are known to be associated with an unfavorable prognosis, including loss of p16 expression and gains of chromosomes 1q and 12. The patient experienced the most rapid downhill course reported to date for intracranial Ewing sarcoma, developing multiple extracranial metastases at 2 months and dying 6 months after the initial operation.
No takes yet. Share an insight, caveat, or question.
Tanboon et al. (2011) conducted a case report in Primary intracranial Ewing sarcoma (n=1). Craniotomy with gross total excision was evaluated on Clinical course and survival. A 22-year-old woman with primary intracranial Ewing sarcoma underwent gross total excision but experienced a rapid downhill course, developing extracranial metastases at 2 months and dying at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: